13G

Company

Xenon Pharmaceuticals Inc.

Filed

February 13, 2017

Accession Number

0001172661-17-000527

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →